Literature DB >> 34082518

Systemic Sarcoidosis Induced by Chemotherapy, Mimicking Metastatic Testicular Carcinoma with 18F-FDG PET/CT

Esra Arslan1, Tamer Aksoy1, Süheyla Ekemen2, Tevfik Fikret Çermik1.   

Abstract

A 34-year-old male patient who had left orchiectomy and received three cycles of chemotherapy for testicular mix germ cell carcinoma was referred for 18fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) for complaints of weight loss and fever. PET/CT showed multiple and progressive 18F-FDG uptakes in supra and infra diaphragmatic lymphatic regions, and multiple abnormal 18F-FDG uptakes were noted in the lytic formed skeletal lesions. Clinicians remain in doubt regarding the multiple metastatic lesions without elevated serum tumor marker levels (alpha-fetoprotein, beta-human chorionic gonadotrophin, CA19-9, and carcinoembryonic antigen). Biopsy of the lytic lesion in the iliac bone revealed granulomatous inflammation suggestive of sarcoidosis. Systemic prednisone at 20-40 mg/daily was started. 18F-FDG PET/CT images showed complete metabolic response to prednisone 8 months following the start of treatment.

Entities:  

Keywords:  18F-FDG PET/CT; Systemic sarcoidosis; testis carcinoma

Year:  2021        PMID: 34082518      PMCID: PMC8185480          DOI: 10.4274/mirt.galenos.2020.51422

Source DB:  PubMed          Journal:  Mol Imaging Radionucl Ther        ISSN: 2146-1414


  8 in total

1.  Multiorgan Involvement of Chemotherapy-Induced Sarcoidosis Mimicking Progression of Lymphoma on FDG PET/CT.

Authors:  Prateek Sanan; Yang Lu
Journal:  Clin Nucl Med       Date:  2017-09       Impact factor: 7.794

Review 2.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

Review 3.  Association between sarcoidosis and testicular carcinoma: a diagnostic pitfall.

Authors:  Philippe Paparel; Marian Devonec; Paul Perrin; Alain Ruffion; Myriam Decaussin-Petrucci; Oguz Akin; Joel Sheinfeld; Bertrand Guillonneau
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2007-09       Impact factor: 0.670

4.  Sarcoidosis and cancer revisited: a long-term follow-up study of 555 Danish sarcoidosis patients.

Authors:  F K Rømer; P Hommelgaard; G Schou
Journal:  Eur Respir J       Date:  1998-10       Impact factor: 16.671

Review 5.  [Sarcoidosis and sarcoid reactions in cancer].

Authors:  M Pavic; P Debourdeau; V Vacelet; H Rousset
Journal:  Rev Med Interne       Date:  2007-10-25       Impact factor: 0.728

6.  FDG-PET/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment.

Authors:  Kentaro Inoue; Ryoi Goto; Hideo Shimomura; Hiroshi Fukuda
Journal:  Springerplus       Date:  2013-03-15

7.  Sarcoid Reactions after Chemotherapy for Hodgkin's Lymphoma.

Authors:  Baldeep Wirk
Journal:  Clin Med Insights Case Rep       Date:  2010-08-04

Review 8.  Sarcoidosis Occurring After Solid Cancer: A Nonfortuitous Association: Report of 12 Cases and Review of the Literature.

Authors:  Aurélie Grados; Mikael Ebbo; Emmanuelle Bernit; Véronique Veit; Karin Mazodier; Rodolphe Jean; Diane Coso; Thérèse Aurran-Schleinitz; Florence Broussais; Reda Bouabdallah; Gwenaelle Gravis; Anthony Goncalves; Marc Giovaninni; Pascal Sève; Bruno Chetaille; Florence Gavet-Bongo; Thierry Weitten; Michel Pavic; Jean-Robert Harlé; Nicolas Schleinitz
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.